Pharmacogenomics & Precision Medicine Archive — Page 1 of 3

Complex scatterplot titled “Transcriptional Breast Cancer Atlas,” showing colored clusters of points labeled Neuroendocrine, Mucinous, HER2E ER, HER2E KIS, LumB, LumA, Fibroblast ER, Immune-dominant, Basal M, Basal IM, Basal BL1, Stem-like, LAR, and Normal, with a compass rose in the lower-left corner.
November 3, 2026

Breast cancer atlas helps chart course for precision oncology

The new map integrates data from more than 7,600 tumors across 22 independent studies and reveals previously hidden forms of breast cancer that differ in prognosis, biology and treatment sensitivity.

(iStock)
May 18, 2026

Study finds benefit in genotype-guided care for depression

Genetic variants known to slow or speed metabolism of drugs for depression and anxiety disorders are very common.

Top-down view of gray canvas sneakers standing on a large yellow circle with a black upward arrow, painted on a dark cobblestone path.
April 8, 2026

Adding steps offsets risk of chronic disease: Study

Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease.

Rows of labeled blood collection tubes with purple caps arranged in a plastic tray, with barcodes visible on several tubes.
March 5, 2026

Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

Weekly pill organizer compartments filled with assorted capsules and tablets, with orange prescription bottles in the background.
February 25, 2026

Patients with atrial fibrillation face higher bleeding risks when treated with 2 common medications

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.

Dan Roden, MD, chats with colleagues during a break in the symposium. (photo by Erin O. Smith)
October 1, 2025

Symposium honors personalized medicine leader Dan Roden

Roden is internationally known for his contributions to understanding arrhythmias and to the field of pharmacogenomics.